Probiotics may alleviate symptoms of hay fever, which may be related to bacteria in our gut and nose.

Published Date: 26 Apr 2023

The dreaded hay fever signs, including itchy eyes, sneezing, and a stuffy nose, have arrived for many people with the arrival of spring. Up to 42% of people experience hay fever, making it a widespread condition. Immune system overreaction is the cause of it.

Read Full News

Latest News

Poultry Firm Recalls Nearly 1.6 Million Dozen Eggs Over Salmonella Risk, FDA Says

The U.S. FDA said on Wednesday that Midwest Poultry Services is recalling nearly 1.6 ⁠million dozen eggs produced in Texas due to potential Salmonella...

CRC Screening in Adults Under 50: Research Reveals Trends

After colorectal cancer screening guidelines were updated in 2021 to lower the screening age to 45, three studies look at how providers are reaching those patients.

Simple Risk Score Is the Best at Detecting Liver Fibrosis

The LiverRisk score outperformed the fibrosis-4 index for detecting moderate or greater fibrosis across all age groups, particularly in younger adults.

How to Predict Iron Therapy Response in IBD

Hepcidin and ferritin-based indices help identify patients with active inflammatory bowel disease who are less likely to respond to iron therapy.

‘A Tiny Blueberry’: How Ingestible Sensors Keep Shrinking

A new thermometer is powerful, accurate, and easily swallowed even by children. Inside the push to make the perfectly sized, perfectly powered ingestible device.

Anxiety May Undermine Treatment Response in Some GERD Cases

Higher anxiety is linked to poorer response to proton pump inhibitor treatment among patients with gastroesophageal reflux disease.

Todays Updates

WHO Introduces Ebola Test, Launches Treatment Trial

Researchers begin testing potential Ebola treatments as WHO expands access to a validated Bundibugyo virus assay during the largest recorded outbreak.

Todays Updates

WHO Introduces Ebola Test, Launches Treatment Trial

Researchers begin testing potential Ebola treatments as WHO expands access to a validated Bundibugyo virus assay during the largest recorded outbreak.

Latest News

The U.S. FDA said on Wednesday that Midwest Poultry Services is recalling nearly 1.6 ⁠million dozen eggs produced in Texas due to potential Salmonella...

After colorectal cancer screening guidelines were updated in 2021 to lower the screening age to 45, three studies look at how providers are reaching those patients.

The LiverRisk score outperformed the fibrosis-4 index for detecting moderate or greater fibrosis across all age groups, particularly in younger adults.

Hepcidin and ferritin-based indices help identify patients with active inflammatory bowel disease who are less likely to respond to iron therapy.

A new thermometer is powerful, accurate, and easily swallowed even by children. Inside the push to make the perfectly sized, perfectly powered ingestible device.

Higher anxiety is linked to poorer response to proton pump inhibitor treatment among patients with gastroesophageal reflux disease.

News All Time

Mastering Recent Advances in Targeted Therapy for GEP-NETs

Mastering Recent Advances in Targeted Therapy for GEP-NETs

Steatosis and Cardiovascular Events; Golimumab Biosimilar OK'd; Daily Stress and IBS

News and commentary from the world of gastroenterology and hepatology

GLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor Types

Accumulating evidence of possible benefit warrants randomized trials, experts say

Danish Duo's Maverick African Research Finds Its Moment in RFK Jr.'s Vaccine Policy

"They became more strident in saying that their findings were real," says one expert

FDA OKs First Treatment for Chronic Hepatitis D Infection

In phase III study, patients taking bulevirtide had ALT normalization and steep drops in HDV RNA

Blood Test for Colon Cancer Screening Gets Guideline Backing

Updated ACS guidance suggests use in those who decline other options

Perfusion Preservation Strategy Boosts Liver Transplant Outcomes

Portal-venous hypothermic oxygenated perfusion reduced incidence of early allograft dysfunction

GLP-1s and Chronic Pancreatitis; Hypoglycemia After Bowel Prep; Lower GI Bleeding

News and commentary from the world of gastroenterology and hepatology

Novel Hep B Drug Delivers Functional Cures in Late-Stage Trials

Findings "will change the landscape" of treatment, researcher says

TIPS Was Tops for Refractory Hydrothorax in Cirrhosis

Majority of patients who received TIPS had a complete clinical response

Enhanced MRI Tops Ultrasound in Catching Early Liver Cancer

MRI approach also led to fewer false referrals

Multicancer Early Detection Test Fails to Reduce Cancers Detected at Late Stages

However, an increase in the detection of stage I/II cancers was observed

'A Grand Slam' in Pancreatic Cancer: Novel Pill Doubles Survival

RASolute 302 findings herald a new standard of care in previously treated patients

Albumin 5% Cut Mortality Rates in Sudden Liver Failure With Other Organ Failure

Treatment may be an effective bridge to transplantation for acute-on-chronic liver failure

Non-Operative Treatment for CRC May Include Observation After Complete Response

No difference in disease-free, overall survival compared with 3 years of maintenance therapy

Saroglitazar Boosts Response Rates in Primary Biliary Cholangitis

More than half of patients saw a biochemical response by 1 year with the novel oral agent

Recommended News For You

Blinatumomab Plus Chemotherapy New Standard for Children With B-Cell ALL

Novel radiotracer identifies biomarker for triple-negative breast cancer

TikTok creators perform 'roles' when sharing their hereditary cancer stories, shaping the health information they share

Check for eating disorders in bipolar disorder patients.

FDA Expands Durvalumab Label to Operable Lung Cancer

Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.

In NPM1-mutated acute myeloid leukemia, MRD Correlates with Allo-Transplant Benefit.

Recommended Articles For You

Advancements in Breast Cancer Treatment: From Chemotherapy to Immunotherapy 

Revolutionizing Cancer Treatment: How Adoptive Cell Therapy is Overcoming Tumor Immune Evasion 

What Is May-Hegglin Anomaly? Understanding this Rare Blood Disorder 

Immunotherapy Breakthroughs: Transforming Cancer Care Across All Oncology Fields 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Journal Club: A well-accepted and safe method for soft tissue sarcoma biopsy.

2.

ASCO: Vepdegestrant ups survival in ER+, HER2− advanced breast cancer with ESR1 mutations

3.

'Cell-in-cell' mechanism explains how blood cancer uses bone marrow to evade treatment

4.

Black women are more likely to die of breast cancer. Close the gap by looking into mammogram studies.

5.

Reduced Suicide Rates in Cancer Patients; Enhanced Circadian Rhythm; HIV Vaccine for Cancer Patients?

1.

Unlocking the Potential of Talquetamab: A Revolutionary Approach to Cancer Treatment

2.

Breakthroughs in Oncology: Advances in Immunotherapy, Radiation & Precision Diagnostics

3.

Radiomics-Based Prediction of Treatment Response in Cancer

4.

Predicting Incidental Prostate Cancer in BPH Surgery Patients

5.

Liquid Biopsies Unveiling the Future of Precision Cancer Management by 2025

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII

3.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

4.

Navigating the Complexities of Ph Negative ALL - Part VI

5.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot